Karla MacDonald

Karla MacDonald - Ipsen US LeadershipVice President, Communications and Patient Advocacy

Karla MacDonald is a global life sciences leader who brings to Ipsen 20 years’ experience guiding business strategy, leading communications and building talent for companies ranging from small biotechs to large pharma. At Ipsen, Karla is responsible for leading communications and patient advocacy across the US and Canada.

Prior to joining Ipsen, Karla held numerous senior positions at Merck & Co, Inc., and served on the Global Communications and R&D division’s executive leadership teams. Most recently, she led International and Corporate Responsibility communications, where she was responsible for advancing Merck’s brand and communications strategy across its 140 markets outside of the US. Before that, Karla led communications for Merck Research Laboratories. Karla has also held strategic counsel roles at MacDougall Biomedical and Feinstein Kean Healthcare (an Ogilvy company), and managed investor relations for Creative BioMolecules.

Karla is a Board Member of the Canadian Entrepreneurs in New England and a lead mentor with Canadian Technology Accelerator, helping tech and biotech companies gain access to in-market entrepreneurial resources to help them grow and compete internationally. She holds a bachelor’s degree in Education and a diploma in Communications from McGill University in Montréal, Canada.

Our mission?

To improve patients’ lives

Acting on this mission has propelled us to become a global biopharmaceutical leader with a focus on innovation and specialty care. We help patients through our expertise in oncology, neuroscience, and rare diseases.

Find out more about us or see other members of our leadership team.


Products and partnerships

Our products

Our mission is to improve patients’ lives.

See our products


Access our development and commercialization teams. We take bold steps to translate your science and innovations into solutions that make a difference for patients in need.

See more on partnering

Products and partnerships

What’s happening now?

See the latest
©2020 Ipsen Biopharmaceuticals, Inc. All rights reserved. June 2020 MP-US-000472